Wound Healing Without Infection
Wound Healing Without Infection integrates antimicrobial strategies, biofilm disruption, regenerative scaffolds, and rapid diagnostics to close traumatic and chronic wounds while preventing infection. Solutions emphasize rugged, portable, and scalable technologies suited to combat casualty care, prolonged-field care, and civilian trauma systems.
Technical Challenges
Preventing and eradicating biofilms that shield bacteria from antibiotics and host defenses
Managing wounds in polytrauma and blast injuries with heavy contamination
Providing effective therapy during delayed evacuation or prolonged field care
Addressing antimicrobial resistance (AMR) without harming tissue regeneration
Emerging Opportunities
Point-of-care diagnostics that rapidly distinguish colonization from invasive infection
Field-deployable antimicrobial delivery systems that sustain therapeutic levels locally
Combined anti-infective and pro-regenerative dressings that work in austere conditions
Validated clinical pathways and decision-support for wound care under prolonged transport
Current and Emerging Technologies in Wound Healing Without Infection
Targeted topical and locally delivered antimicrobials
Sustained-release antibiotic beads, antibiotic-loaded hydrogels and nanoscale carriers to achieve high local concentrations while minimizing systemic toxicity and AMR selection pressure.
Biofilm disruptors and enzymatic adjuvants
Agents that break extracellular polymeric substances, quorum-sensing inhibitors, and bacteriophage cocktails to unmask bacteria for antimicrobial penetration and immune clearance.
Antimicrobial dressings and regenerative matrices
Composite scaffolds combining silver, antimicrobial peptides, or antibiotics with collagen/HA matrices and growth factors to both suppress infection and support granulation and re-epithelialization.
Rapid point-of-care diagnostics and biosensors
Handheld molecular assays, host-response biomarkers, and wearable sensors that detect bacterial load, virulence factors, or inflammatory signatures within minutes to guide early intervention.
Portable negative-pressure and adjunctive devices
Lightweight NPWT systems, instillation devices, and field-compatible wound lavage technologies that remove bioburden, reduce edema, and promote tissue approximation in austere settings.
Cellular, growth-factor and gene-based regenerative therapies
Autologous/allogeneic cell therapies, platelet-rich plasma, and localized gene delivery to accelerate repair while engineered controls limit infection risk and inflammation.
Antimicrobial coatings for implants and fixation devices
Surface-modified plates, screws, and grafts with sustained antimicrobial release or contact-killing surfaces to prevent implant-associated infections in reconstructive surgery.
AI-enabled decision support and telemedicine for wound triage
Machine-learning models that integrate images, biosensor data, and clinical variables to prioritize evacuation, recommend therapies, and support remote clinicians during prolonged care.
Importance to Military Medicine
Preserve life and limb in combat casualty care
Rapid infection control reduces sepsis, amputation rates, and morbidity after blast and penetrating trauma.
Enable prolonged and distributed care
Field-capable solutions sustain tissue viability during delayed evacuation or austere operations, maintaining force readiness.
Reduce burden of antimicrobial resistance
Targeted local therapies and diagnostics limit systemic antibiotic use and help steward valuable antimicrobials.
Support recovery and return-to-duty
Faster, infection-free wound closure reduces long-term disability and expedites rehabilitation for service members.
Alignment with the MTEC Mission
Accelerates translation of military-relevant wound technologies from lab to field deployment, consistent with MTEC’s mission.
Supports DoD priorities for combat casualty care, prolonged field care, and force health protection.
Enables dual-use outcomes by advancing solutions that benefit civilian trauma centers and disaster response.
Leverages multidisciplinary member expertise—industry, academia, and government—to de-risk and scale promising interventions.
Dual-Use (Military + Civilian) Applications
Civilian trauma and burn centers: accelerated translation improves outcomes for motor vehicle and industrial injuries.
Chronic wound management: innovations reduce hospital stays and costs for diabetic and vascular ulcers.
Mass-casualty and disaster response: portable diagnostics and therapies enable rapid triage and infection control.
Commercial medical devices and regenerative medicine markets benefit from validated, scalable wound technologies.
Explore MTEC Members with Wound Healing Without Infection Capabilities
MTEC members bring translational expertise in biomaterials, diagnostics, clinical trials, and regulatory strategy. Explore member profiles to find partners with capabilities in antimicrobials, biofilm science, regenerative scaffolds, and field-deployable devices.
135 Members with Wound Healing Without Infection capabilities.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.
Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.
FiteBac Technology/FiteBac Pharma's K21 uniquely targets the underlying disease state, given that most diseases involve microbial-associated inflammation and mitochondrial dysfunction. FiteBac Technology innovations stem from the work of numerous international academic research scientists. FiteBac Pharma K21 is the blockbuster antimicrobial small molecule designed to modulate biological, immunological, and metabolic systems for treating a wide range of infectious and inflammatory diseases. This patented drug substance has demonstrated the ability to safely eliminate bacterial, fungal, and viral infections, enhance innate immunity, induce mitophagy while improving mitochondrial and cellular metabolism, accelerate wound healing, and even promote the development of zebrafish and chickens, leading to increased adult mass. Rigorous research from Dr. Bhupesh Prusty's laboratory and Dr Christopher Rongo's laboratory is focused on various aspects of mitochondrial remodeling and reprograming, as well as mitochondrial-to-nuclear signaling with K21.
Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. The company focuses on purpose-driven innovation to empower healthcare professionals and enhance patient outcomes across various medical fields.
MediCarbone is an Arizona-based orthopedic medical device startup founded in 2019, focused on revolutionizing bone fracture repair through minimally invasive, customized intramedullary nailing technology. The company utilizes patented carbon-fiber-reinforced polymer applications and AI technology to enhance patient outcomes in orthopedic treatments.
Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.
SanaHeal is dedicated to developing next-generation bioadhesive technologies inspired by nature to solve significant challenges in healthcare. Their innovative solutions are designed to adhere to wet and uneven surfaces, providing rapid and robust adhesion for various medical applications.
SERDA Therapeutics is a clinical stage biopharmaceutical company focused on developing innovative solutions for wound care, particularly in the treatment of burn injuries and chronic ulcers. The company aims to provide fast and effective therapeutic debridement through its proprietary enzymatic product, SN514, which is designed to enhance healing by selectively removing necrotic tissue.
Sonogen Medical Inc. is dedicated to researching, developing, and commercializing next-generation ultrasonic bone fracture healing technology. The company combines expertise in fluid mechanics, biophysics, sonar, and medical ultrasound to create safe and effective devices for bone healing.
The Institute for Integrative & Innovative Research (I3R) at the University of Arkansas is dedicated to pioneering solutions to complex societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I3R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.
Neuraptive Therapeutics is a biotechnology company focused on developing novel therapies to improve outcomes in peripheral nerve injuries (PNI). Their mission is to enhance the quality and speed of recovery for patients suffering from traumatic injuries or undergoing reconstructive surgeries, utilizing innovative technologies such as NTX-001, a nerve fusion system, and specialized microsurgical instruments.
Spartan Medical is a medical solutions company serving VA medical centers, Department of Defense (DoD) facilities, civilian hospitals, and ambulatory surgery centers across the United States and internationally. The company specializes in advanced medical devices, surgical solutions, and support services, with a history of adapting to emergent healthcare challenges and logistical demands. Spartan Medical has provided solutions in public health crises, such as COVID-19 mitigation, and delivers comprehensive procurement, logistical, and operational support for healthcare organizations. It operates as a certified Service-Disabled Veteran-Owned Small Business (SDVOSB) and is recognized for its significant presence in federal healthcare contracting.
The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.
Harmac is a global contract design and manufacturing organization specializing in single-use medical devices. With over four decades of experience, Harmac provides comprehensive services including product design and development, advanced manufacturing, automation, value engineering, quality assurance, and packaging and sterilization. The company is known for its operational excellence, regulatory compliance, and commitment to sustainability and community engagement. Harmac operates facilities across the United States, Ireland, and Mexico, supporting customers worldwide and across a range of clinical applications. ISO 13485 Certified and FDA Registered.
Memsel is a biotechnology research and development company dedicated to enhancing health and combatting infections through advanced phage therapies and targeted delivery systems. The company aims to transform healthcare solutions across human, animal, and plant domains, addressing critical health challenges and antibiotic resistance.
Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.

University of California San Francisco
TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness
TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.
Arizona State University
ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience
Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.
University of Pittsburgh
Topical Metformin Lotion for Tendinopathy Prevention
University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.
Theradaptive
Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE
Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.